Merck Foundation announced the Call for Application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities through its Merck Capacity Advancement Program with the aim to building a platform for diabetes and hypertension experts across the globe.
The CEO of Merck Foundation, Dr. Rasha Kelej said, “I am very proud to see our newly established platform of Diabetes and Hypertension Experts has grown in one year. This encourages us to continue and expand 2018 Merck Diabetes and Hypertension Awards to universities in more countries in Africa and Asia such as Senegal, Cameroon, Gabon, Guinea, Niger, Philippines, Thailand, and Vietnam to join our mission to improve access to quality Diabetes and hypertension care in the two continents. “
She further added, “All Merck Diabetes and Hypertension awards winners have joined Merck Foundation Alumni with our oncology and Fertility scholars and fellows from different countries to exchange experience & knowledge and network, this is a very important initiative for us. I personally oversee this platform to ensure the success of its interaction and sustainability “.
Merck Diabetes and Hypertension Awards 2018 will be rolled out in many African and Asian Universities in more than 30 countries, as a part of Merck Foundation’s commitment to building Diabetes and Hypertension healthcare capacity and improving access to quality and sustainable healthcare solutions in developing countries.
The theme for Merck Diabetes Award 2018 is ‘Every day is a Diabetes Day,’ and the theme for Merck Hypertension Award is ‘What a Healthy Heart Needs.’ All medical postgraduates and final year undergraduates are invited to apply for the awards. The participants need to submit a one-page concept paper about:
The scientific committee will review the submissions, and the winners of Merck Diabetes and Hypertension awards will receive the online one-year postgraduate diploma in Diabetes Management and Preventive Cardiovascular Medicine from the University of South Wales, UK.
The deadline for the submission is 30th September 2018.
For French-speaking countries, the winners will receive online three-month Diabetes foundation diploma in French and accredited by Royal colleague of General Practitioners, UK.
Click here to know more.
Interested students can submit the concept papers at:
Applicants Name, Gender, Age, Country, University/College, Expected year of completion of MBBS/Medical Graduation, address, email and Mobile number must be provided with the submission.
Watch the testimonies of medical students from Africa and Asia on the importance of Merck Diabetes and Hypertension Awards
One Click on icon below to
Download Merck Foundation App
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.